Xcout Intel
Jocasta Neuroscience, Inc.
Jocasta Neuroscience, Inc. is a preclinical-stage biotechnology company located in Scottsdale, Arizona and San Francisco, California. The company specializes in developing longevity-focused therapies for cognitive impairment.
Subscribe to see Jocasta Neuroscience, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Jocasta Neuroscience, Inc. at a glance
Jocasta Neuroscience, Inc. is a biotechnology company headquartered in United States. It has raised at least $66.6M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $35M in August 2025. Xcout tracks 9 named people at Jocasta Neuroscience, Inc., including Albert Agro (CEO).
Jocasta Neuroscience, Inc. leadership
- Albert AgroCEO
- Dr. Albert AgroChief Executive Officer
- Jordan DubowCMO
- Todd VerdoornCSO
- Nathaniel (Ned) DavidFounding Member
- Albert AgroExecutive Officer
3 more named people on record for Jocasta Neuroscience, Inc., with roles, board committees and tenure — see the full roster →
Jocasta Neuroscience, Inc. funding rounds
At least $66.6M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $35M | — | |
| SEC Form D filing | $31.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Jocasta Neuroscience, Inc. competitors
A few of Jocasta Neuroscience, Inc.'s closest competitors — see the full list of competitors and alternatives →
Recognify Life Sciences is a clinical-stage biotechnology company located in California, focusing on developing treatments for cognitive impairment associated with central nervous system disorders.
Cognition Therapeutics, Inc. is a public, clinical-stage biopharmaceutical company founded in 2007 and headquartered in Purchase, New York. The company develops therapies designed to protect neurons and advance treatments for patients living with age-related neurodegenerative diseases.
Cajal Neuroscience (Cajal Therapeutics Inc.) is a biotechnology company headquartered in Seattle, Washington. The company is dedicated to advancing therapeutic pipelines in neuroscience research.
Myrobalan Therapeutics is a pre-clinical biotechnology company headquartered in Medford, Massachusetts, focused on developing oral small molecule therapies for central nervous system and neurodegenerative diseases. The company targets novel mechanisms to create neurorestorative treatments for CNS disorders.
Juvenescence Ltd is a life sciences and clinical-stage AI-enabled biotech company headquartered in Dublin, Ireland, dedicated to extending healthy lifespan through novel medicines.
Amygdala Neurosciences Inc is an independent small biopharmaceutical company headquartered in San Francisco, California. Its mission is to invent and develop first-in-class therapeutics.
Get Jocasta Neuroscience, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Jocasta Neuroscience, Inc. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access